Clinical trial

Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive…

NCT01164592 · ResMed, Industry · Completed

Key facts

NCT number NCT01164592
Title Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
Official title SERVE-HF: Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
Acronym MS
Lead sponsor ResMed, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Heart Failure, Sleep Disorder, Cheyne Stokes Respiration
Intervention type Device
Interventions adaptive servoventilation (ASV)
Enrollment 312
Start date Aug 1, 2012
Primary completion Apr 1, 2015
Completion Jun 1, 2015
First posted Jul 16, 2010
Last update posted Aug 7, 2015
Countries Australia, Czechia, Finland, France, Germany, Netherlands, Switzerland, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies